D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 55 Citations 9,743 233 World Ranking 2741 National Ranking 239

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Tuberculosis

His scientific interests lie mostly in Tuberculosis, Immunology, Internal medicine, Mycobacterium tuberculosis and Surgery. His research integrates issues of Meta-analysis, AIDS-Related Opportunistic Infections and Drug resistance in his study of Tuberculosis. His studies deal with areas such as Tuberculin, Disease and Lung as well as Immunology.

His study in Internal medicine is interdisciplinary in nature, drawing from both Tuberculosis diagnosis and Acquired immunodeficiency syndrome. His Mycobacterium tuberculosis study combines topics in areas such as Psychological intervention, Antibiotics, Gerontology and Contact tracing. His Surgery research integrates issues from Reproductive health, Primary care, Family medicine, Breast feeding and Medical school.

His most cited work include:

  • Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials (430 citations)
  • Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials (430 citations)
  • Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis (395 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Tuberculosis, Immunology, Internal medicine, Mycobacterium tuberculosis and Disease. He is interested in Latent tuberculosis, which is a branch of Tuberculosis. His Immunology study combines topics from a wide range of disciplines, such as Bronchoalveolar lavage, Lung and Acquired immunodeficiency syndrome.

His research ties Sputum and Internal medicine together. His work deals with themes such as Tuberculin, Drug resistance and Virology, which intersect with Mycobacterium tuberculosis. His research links Intensive care medicine with Disease.

He most often published in these fields:

  • Tuberculosis (75.25%)
  • Immunology (36.87%)
  • Internal medicine (33.84%)

What were the highlights of his more recent work (between 2018-2021)?

  • Tuberculosis (75.25%)
  • Internal medicine (33.84%)
  • Intensive care medicine (12.12%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Tuberculosis, Internal medicine, Intensive care medicine, Disease and Family medicine. His Tuberculosis research is multidisciplinary, relying on both Regimen, Incidence and Cohort. The study incorporates disciplines such as Epidemiology, Psychosocial, Systematic review, Standard care and Drug resistance in addition to Intensive care medicine.

His Disease study deals with Pulmonary disease intersecting with Anesthesia, Oxygen saturation, Exacerbation and Pulse oximetry. His Family medicine research includes elements of Psychological intervention, Observational study, Randomized controlled trial and Health care. Marc Lipman has included themes like Tuberculin and Relative risk in his Latent tuberculosis study.

Between 2018 and 2021, his most popular works were:

  • 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. (63 citations)
  • The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions. (52 citations)
  • Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial (46 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Acquired immunodeficiency syndrome

His primary scientific interests are in Tuberculosis, Internal medicine, Coronavirus disease 2019, Mycobacterium tuberculosis and Biomarker. The study incorporates disciplines such as Odds ratio, Epidemiology and Intensive care medicine in addition to Tuberculosis. His research on Internal medicine frequently links to adjacent areas such as Isoniazid.

His studies in Coronavirus disease 2019 integrate themes in fields like 2019-20 coronavirus outbreak, Logistic regression, Prognostic models and Emergency medicine. His research investigates the link between Mycobacterium tuberculosis and topics such as Cohort that cross with problems in Relative risk and Transmission. His Tuberculosis diagnosis study combines topics from a wide range of disciplines, such as Disease management and Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

Punam Mangtani;Ibrahim Abubakar;Cono Ariti;Rebecca Beynon.
Clinical Infectious Diseases (2014)

796 Citations

Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

Martina Sester;Giovanni Sotgiu;Christoph Lange;Claudia Giehl.
European Respiratory Journal (2011)

680 Citations

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

R A M Breen;C J Smith;H Bettinson;S Dart.
Thorax (2004)

445 Citations

Drug-resistant tuberculosis: time for visionary political leadership

Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione.
Lancet Infectious Diseases (2013)

335 Citations

Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis

I Abubakar;L Pimpin;C Ariti;R Beynon.
Health Technology Assessment (2013)

325 Citations

Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

Chloe I. Bloom;Christine M. Graham;Matthew P. R. Berry;Matthew P. R. Berry;Fotini Rozakeas.
PLOS ONE (2013)

287 Citations

Outcome of HIV-Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy

Keertan Dheda;Fiona C. Lampe;Margaret A. Johnson;Marc C. Lipman.
The Journal of Infectious Diseases (2004)

285 Citations

'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19.

Swapna Mandal;Joseph Barnett;Simon E Brill;Jeremy S Brown.
Thorax (2021)

264 Citations

Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral Therapy

Stephen D. Lawn;Robert J. Wilkinson;Marc C. I. Lipman;Robin Wood.
American Journal of Respiratory and Critical Care Medicine (2008)

259 Citations

MMP-1 drives immunopathology in human tuberculosis and transgenic mice

Paul Elkington;Takayuki Shiomi;Ronan Breen;Robert K. Nuttall.
Journal of Clinical Investigation (2011)

251 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marc Lipman

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 100

Ibrahim Abubakar

Ibrahim Abubakar

University College London

Publications: 95

Thomas J. Scriba

Thomas J. Scriba

University of Cape Town

Publications: 68

Graeme Meintjes

Graeme Meintjes

University of Cape Town

Publications: 60

Alimuddin Zumla

Alimuddin Zumla

University College London

Publications: 60

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Publications: 59

Keertan Dheda

Keertan Dheda

University of Cape Town

Publications: 54

Stephen D. Lawn

Stephen D. Lawn

London School of Hygiene & Tropical Medicine

Publications: 52

Delia Goletti

Delia Goletti

Istituto Sperimentale Italiano Lazzaro Spallanzani

Publications: 50

Ben J. Marais

Ben J. Marais

University of Sydney

Publications: 50

Giovanni Battista Migliori

Giovanni Battista Migliori

Queen Mary University of London

Publications: 50

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 47

Anne O'Garra

Anne O'Garra

The Francis Crick Institute

Publications: 39

Willem A. Hanekom

Willem A. Hanekom

University College London

Publications: 38

Christoph Lange

Christoph Lange

University of Lübeck

Publications: 38

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 37

Trending Scientists

Mengdao Xing

Mengdao Xing

Xidian University

Fabrizio Silvestri

Fabrizio Silvestri

Sapienza University of Rome

Stéphane Moreau

Stéphane Moreau

Université de Sherbrooke

Hu Ding

Hu Ding

Shanghai University

John F. Geisz

John F. Geisz

National Renewable Energy Laboratory

Abdul Wahid

Abdul Wahid

University of Agriculture Faisalabad

Larry C. Purcell

Larry C. Purcell

University of Arkansas at Fayetteville

Inger Björck

Inger Björck

InnovaFood

Kay-Christian Emeis

Kay-Christian Emeis

Universität Hamburg

David B. Scott

David B. Scott

Dalhousie University

Nathaniel L. Bindoff

Nathaniel L. Bindoff

University of Tasmania

Kristine B. Walhovd

Kristine B. Walhovd

Oslo University Hospital

Philip M. Podsakoff

Philip M. Podsakoff

University of Florida

Dina Birman

Dina Birman

University of Miami

David O. Hodge

David O. Hodge

Mayo Clinic

Roman Jakobson

Roman Jakobson

Harvard University

Something went wrong. Please try again later.